化疗外流引起软组织缩模仿感染:一个纵向案例研究
Michael Nguyen1, Luke Borders1, Jacqueline T Wesolow2
1Internal Medicine, Morsani College of Medicine, University of South Florida Health, Tampa, USA.
Cureus
|March 4, 2024
概括
伸展性损伤虽然很少见,但可以模仿严重的疾病,如死性膜炎 (NF). 及时诊断和治疗对于患者的结果至关重要,特别是在化疗患者中.
科学领域:
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
- 皮肤病学 皮肤病学
背景情况:
- 伸展性损伤很少发生,但可能导致严重的并发症,包括组织死和感染.
- 准确的诊断是具有挑战性的,因为症状重叠与诸如死角性膜炎 (NF) 和细胞炎等疾病.
- 早期发现和管理对于预防发病率和死亡率至关重要.
研究的目的:
- 介绍一个模仿NF外流伤的案例研究.
- 讨论诊断和管理的外流伤害.
- 为了区分外流性损伤与其他类似NF的疾病.
主要方法:
- 一个44岁的男性患有B细胞急性淋巴细胞白血病,正在接受化疗的病例报告.
- 对外流动损伤的诊断和治疗策略的审查.
- 与类似于NF的疾病进行比较.
主要成果:
- 患者的外导损伤最初呈现出类似于NF的症状.
- 延迟诊断和治疗导致感染并发症.
- 突出了扩散的适当管理协议.
结论:
- 伸缩损伤需要仔细评估,以区分它们与NF.
- 及时和准确的诊断对于有效治疗和预防严重后果至关重要.
- 对于管理化疗患者的临床医生来说,意识到模仿NF的情况至关重要.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
01:16Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K